"MNKD" - "The Next Big Thing In Biotech - Mannkind"
Mannkind's annual shareholder meeting is being held on June 2. Mannkind's billionaire C.E.O., Al Mann, recently announced that the company is engaged in partnership talks with a number of big pharma companies and had multiple options for "non-dilutive" funding available to the company.
There are currently about 25,000,000 shares short which is about 40% of the float. A partnership announcement could easily send the share price to the $12.00-$15.00 range.
HGSI went from $2.55/share to over $35.00 after its partnership with Glaxo was announced.
A rumor on flyonthewall.com several weeks ago indicated that Eli Lilly was readying a $12.50/share offer for Mannkind.
The share price should be in the $5.25 range by the time of the meeting